• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中125I-甘丙肽结合位点:海马亚区增加,尾状核减少。

125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus.

作者信息

Rodríguez-Puertas R, Nilsson S, Pascual J, Pazos A, Hökfelt T

机构信息

Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.

出版信息

J Neurochem. 1997 Mar;68(3):1106-13. doi: 10.1046/j.1471-4159.1997.68031106.x.

DOI:10.1046/j.1471-4159.1997.68031106.x
PMID:9048756
Abstract

Using iodinated human galanin and autoradiography, galanin binding sites were studied in cortical and hippocampal areas and in some brainstem nuclei in the brains of eight patients with senile dementia of the Alzheimer type (SDAT) and of nine matched control cases. The highest density of binding sites was found in the substantia nigra with a less intense labeling in the hippocampus and cortical regions. In the SDAT cases a significant increase in number of galanin binding sites was found in some hippocampal areas, a decrease in the caudate nucleus, and no significant changes in frontal and entorhinal cortices. These findings suggest that some central galanin systems may be deranged in SDAT.

摘要

利用碘化人甘丙肽和放射自显影技术,对8例阿尔茨海默型老年痴呆(SDAT)患者及9例匹配的对照者大脑的皮质、海马区和一些脑干核团中的甘丙肽结合位点进行了研究。结合位点密度最高的是黑质,海马和皮质区域的标记强度较低。在SDAT病例中,发现海马某些区域的甘丙肽结合位点数量显著增加,尾状核减少,额叶和内嗅皮质无显著变化。这些发现提示,SDAT患者的一些中枢甘丙肽系统可能紊乱。

相似文献

1
125I-galanin binding sites in Alzheimer's disease: increases in hippocampal subfields and a decrease in the caudate nucleus.阿尔茨海默病中125I-甘丙肽结合位点:海马亚区增加,尾状核减少。
J Neurochem. 1997 Mar;68(3):1106-13. doi: 10.1046/j.1471-4159.1997.68031106.x.
2
Preservation of [125I]galanin binding sites despite loss of cholinergic neurones to the hippocampus in Alzheimer's disease.在阿尔茨海默病中,尽管海马体的胆碱能神经元丧失,但[125I]甘丙肽结合位点得以保留。
Brain Res. 1991 Dec 24;568(1-2):303-6. doi: 10.1016/0006-8993(91)91414-v.
3
Decreased densities of dopamine D1 receptors in the putamen and hippocampus in senile dementia of the Alzheimer type.阿尔茨海默型老年痴呆症患者壳核和海马体中多巴胺D1受体密度降低。
Brain Res. 1988 Dec 13;475(1):164-7. doi: 10.1016/0006-8993(88)90212-0.
4
Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis.早发性和晚发性阿尔茨海默病患者基底前脑内甘丙肽受体可塑性:一项体外放射自显影分析
Neuropharmacology. 2000 Jun 8;39(8):1404-12. doi: 10.1016/s0028-3908(00)00011-3.
5
Galanin receptors in the post-mortem human brain. Regional distribution of 125I-galanin binding sites using the method of in vitro receptor autoradiography.人死后大脑中的甘丙肽受体。采用体外受体放射自显影法对¹²⁵I-甘丙肽结合位点进行区域分布研究。
Neurosci Lett. 1990 Dec 11;120(2):179-82. doi: 10.1016/0304-3940(90)90032-5.
6
Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.阿尔茨海默病和亨廷顿病中L-谷氨酸结合的改变。
Science. 1985 Mar 22;227(4693):1496-9. doi: 10.1126/science.2858129.
7
Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile.
J Neural Transm. 1987;69(1-2):19-32. doi: 10.1007/BF01244094.
8
Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients.非神经疾病患者及阿尔茨海默型老年痴呆症患者大脑中的胆碱能受体结合与放射自显影
Brain Res. 1983 May 16;267(2):271-80. doi: 10.1016/0006-8993(83)90879-x.
9
Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis.早期阿尔茨海默病患者杏仁核内甘丙肽受体的过表达:体外放射自显影分析
J Chem Neuroanat. 2002 Jul;24(2):109-16. doi: 10.1016/s0891-0618(02)00034-0.
10
[125I]-Galanin binding in brain of wildtype, and galanin- and GalR1-knockout mice: strain and species differences in GalR1 density and distribution.野生型、甘丙肽及甘丙肽受体1基因敲除小鼠大脑中[125I] - 甘丙肽结合:甘丙肽受体1密度及分布的品系和种属差异
Neuroscience. 2005;131(2):407-21. doi: 10.1016/j.neuroscience.2004.11.023.

引用本文的文献

1
Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer's Disease.阿尔茨海默病三转基因小鼠模型中神经脂质信号和特定脂质种类的调制。
Int J Mol Sci. 2021 Nov 12;22(22):12256. doi: 10.3390/ijms222212256.
2
Effects of Rivastigmine on Brain Functional Networks in Patients With Alzheimer Disease Based on the Graph Theory.基于图论的瑞伐他汀对阿尔茨海默病患者脑功能网络的影响。
Clin Neuropharmacol. 2021;44(1):9-16. doi: 10.1097/WNF.0000000000000427.
3
Hippocampal plasticity during the progression of Alzheimer's disease.
阿尔茨海默病进展过程中的海马可塑性。
Neuroscience. 2015 Nov 19;309:51-67. doi: 10.1016/j.neuroscience.2015.03.006. Epub 2015 Mar 12.
4
Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2.内源性甘丙肽通过激活甘丙肽受体-2保护体外培养的小鼠海马神经元免受淀粉样毒性的影响。
J Alzheimers Dis. 2011;25(3):455-62. doi: 10.3233/JAD-2011-110011.
5
Neuroprotective role for galanin in Alzheimer's disease.甘丙肽在阿尔茨海默病中的神经保护作用。
Exp Suppl. 2010;102:143-62. doi: 10.1007/978-3-0346-0228-0_11.
6
Galanin and its receptors in neurological disorders.加兰素及其受体与神经疾病
Neuromolecular Med. 2005;7(1-2):157-80. doi: 10.1385/NMM:7:1-2:157.
7
Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease.甘丙肽:阿尔茨海默病的神经生物学机制及治疗潜力
CNS Drug Rev. 2001 Winter;7(4):445-70. doi: 10.1111/j.1527-3458.2001.tb00210.x.
8
Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.甘丙肽与乙酰胆碱在啮齿动物记忆任务及阿尔茨海默病中的相互作用。
J Psychiatry Neurosci. 1997 Nov;22(5):303-17.